Cerebrospinal fluid analysis from physiological principles and lumbar puncture to analytical interpretation in clinical neurology

Cerebrospinal fluid (CSF) is a clear, sterile ultrafiltrate of plasma produced primarily by the choroid plexuses at a rate of approximately 500 mL per day, with a circulating volume of 125–150 mL in adults. Disruption of the blood–brain barrier (BBB) and blood-CSF barrier (BCB) underpins a wide spectrum of neurological diseases. This review provides a comprehensive and practically oriented analysis of CSF physiology, the technical conduct of lumbar puncture (LP), and the structured clinical interpretation of CSF biomarkers across three diagnostic phases: emergency, basic, and extensive. A narrative review of the literature was conducted, integrating current guidelines, reference intervals, and diagnostic accuracy data for the main CSF analytes and biomarkers used in clinical neurology practice. Emergency analysis — encompassing global cell counts, CSF glucose (and CSF/serum ratio), lactate, and macroscopic appearance — targets acute inflammation and hemorrhage, including subarachnoid hemorrhage. Basic analysis evaluates BBB/BCB integrity and intrathecal inflammation through total protein quantification (age-partitioned), albumin quotients, immunoglobulin levels, and oligoclonal bands, with established roles in diagnosing multiple sclerosis, Guillain-Barré syndrome, and infectious meningitis. Extensive analysis incorporates specialized assays for neurodegenerative markers; alterations in CSF amyloid-beta 42 have been shown to precede clinical Alzheimer’s onset by up to 18 years in longitudinal cohort studies, followed sequentially by changes in p-Tau-181 (11 years) and t-Tau (10 years). Rigorous LP technique, systematic pre-analytical care, and a structured, phase-based approach to CSF interpretation are essential for the accurate diagnosis of infectious, inflammatory, and neurodegenerative CNS pathologies. The integration of classical and emerging biomarkers positions CSF analysis as an increasingly critical tool in clinical neurology.

Authors

Institutions

Publication Details

Journal
Discover Neuroscience
Published
2026-09-17
DOI
https://doi.org/10.1186/s13064-026-00329-7
Primary Topic
Cerebrospinal fluid and hydrocephalus
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
article

Cerebrospinal fluid analysis from physiological principles and lumbar puncture to analytical interpretation in clinical neurology

Leila Antonângelo, Edy Alyson Ribeiro, Hélio Rodrigues Gomes
Discover Neuroscience
Cerebrospinal fluid and hydrocephalus
article

Cerebrospinal fluid analysis from physiological principles and lumbar puncture to analytical interpretation in clinical neurology

Leila Antonângelo, Edy Alyson Ribeiro, Hélio Rodrigues Gomes
article en

Abstract

Cerebrospinal fluid (CSF) is a clear, sterile ultrafiltrate of plasma produced primarily by the choroid plexuses at a rate of approximately 500 mL per day, with a circulating volume of 125–150 mL in adults. Disruption of the blood–brain barrier (BBB) and blood-CSF barrier (BCB) underpins a wide spectrum of neurological diseases. This review provides a comprehensive and practically oriented analysis of CSF physiology, the technical conduct of lumbar puncture (LP), and the structured clinical interpretation of CSF biomarkers across three diagnostic phases: emergency, basic, and extensive. A narrative review of the literature was conducted, integrating current guidelines, reference intervals, and diagnostic accuracy data for the main CSF analytes and biomarkers used in clinical neurology practice. Emergency analysis — encompassing global cell counts, CSF glucose (and CSF/serum ratio), lactate, and macroscopic appearance — targets acute inflammation and hemorrhage, including subarachnoid hemorrhage. Basic analysis evaluates BBB/BCB integrity and intrathecal inflammation through total protein quantification (age-partitioned), albumin quotients, immunoglobulin levels, and oligoclonal bands, with established roles in diagnosing multiple sclerosis, Guillain-Barré syndrome, and infectious meningitis. Extensive analysis incorporates specialized assays for neurodegenerative markers; alterations in CSF amyloid-beta 42 have been shown to precede clinical Alzheimer’s onset by up to 18 years in longitudinal cohort studies, followed sequentially by changes in p-Tau-181 (11 years) and t-Tau (10 years). Rigorous LP technique, systematic pre-analytical care, and a structured, phase-based approach to CSF interpretation are essential for the accurate diagnosis of infectious, inflammatory, and neurodegenerative CNS pathologies. The integration of classical and emerging biomarkers positions CSF analysis as an increasingly critical tool in clinical neurology.

Discover NeuroscienceVol. 21(1)
Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo (BR), Departamento de Ciência e Tecnologia (BR)
Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
Good health and well-being
Openalex Percentile: Top 16%
Cerebrospinal fluid and hydrocephalus
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.